embusartan has been researched along with losartan in 3 studies
| Studies (embusartan) | Trials (embusartan) | Recent Studies (post-2010) (embusartan) | Studies (losartan) | Trials (losartan) | Recent Studies (post-2010) (losartan) |
|---|---|---|---|---|---|
| 8 | 1 | 0 | 7,231 | 1,245 | 2,118 |
| Protein | Taxonomy | embusartan (IC50) | losartan (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 9.01 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.882 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.019 | |
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.0018 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.019 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0247 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0234 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0032 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.047 | |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.025 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0118 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.019 | |
| Platelet glycoprotein VI | Homo sapiens (human) | 4 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.1481 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.2884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iouzalen, L; Marche, P; Stepien, O | 1 |
| Leenen, FH; Zhang, J | 1 |
| Leenen, FH; Tan, J; Wang, JM | 1 |
3 other study(ies) available for embusartan and losartan
| Article | Year |
|---|---|
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles | 1999 |
Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Peripheral Nervous System; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sodium; Tetrazoles | 2001 |
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
Topics: Angiotensin Receptor Antagonists; Animals; Blood-Brain Barrier; Central Nervous System; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Losartan; Male; Protein Binding; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles | 2003 |